Please assess the completion status of the following clinical trial:

Trial Title: In-vivo Efficacy of Patient Preoperative Prep

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE3
- Number of Arms: 3.0

Eligibility Criteria:
Inclusion Criteria:~* Subjects of any race~* Subjects in good health~* Minimum skin flora baseline requirements on abdomen and groin~* Skin free of tattoos, dermatoses, abrasions, cuts, lesions, or other skin disorder near or on the applicable test area.~Exclusion Criteria:~* Topical or systemic antimicrobial exposure within 14 days prior to screening and treatment days, including antibiotics.~* Subjects with a history of skin sensitivity, skin allergies, or skin cancer.~* Subjects who are pregnant, attempting pregnancy or nursing.

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- ZP (70% IPA) (Type: EXPERIMENTAL): Isopropyl alcohol (IPA) 70%
- ChloraPrep (Type: ACTIVE_COMPARATOR): Chlorhexidine gluconate (CHG) 2% / Isopropyl alcohol (IPA) 70%
- ZP Vehicle (Type: PLACEBO_COMPARATOR): ZP without IPA

Based on this trial design, predict the completion outcome and termination type (if applicable).